Vascular Patches Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)

Vascular Patches Market Dynamics

Technological Innovations in Material Are Key Market Trend

• Companies are focusing on the development of synthetic materials to increase their biocompatibility and reduce the risk of complications, such as infection, inflammation, and rejection in case of transplant surgeries.
• The usage of vascular patches made from resorbable and bioresorbable materials is beneficial in pediatric procedures, where long-term foreign material presence is undesirable.
• Additionally, the development of biological materials derived from animal tissue and natural tissue offers higher performance, biocompatibility, and safety advancement over the synthetic tissues.
• Composite materials, which combine both the synthetic and biological materials, provide improved durability, reduced risk of infection, and enhanced tissue regeneration.
• Furthermore, with the integration of nanotechnology in vascular patches enhances their mechanical properties, biocompatibility, and functionality.
• In May 2024 Teijin Limited launched SYNFOLIUM, a cardiovascular surgical patch made from both bio-absorbable and non-absorbable yarns and coated with cross-linked gelatin.
• The 3D printing technology enables the development of highly customized vascular patches to improve fit and effectiveness.

Increasing Geriatric Population and Rising Vascular Disease Prevalence Drive Market

• The geriatric population, which creates a heavy burden on the healthcare infrastructure of the U.S. due to its high risk of cardiovascular diseases, is a major driver for the market.
• The growth of the global geriatric population is a major factor behind the rising prevalence of cardiovascular diseases, aneurysms, and cancer.
• The WHO says that 1 in 6 people globally will be aged 60 years or more by 2030, with this population rapidly increasing from 1 billion in 2020 to 1.4 billion.
• By 2050, the global population in the 60 and above age group will be 2.1 billion.
• The number of persons aged 80 years and above will triple from 2020 to 2050, reaching 426 million.
• The American Heart Association estimates the CVD incidence in the U.S. in the population aged 40–59 years at around 40%, about 75% in the age group of 60–79, and roughly 86% in those over the age of 80.
• Furthermore, with the increasing focus on the cardiovascular health globally governments and healthcare organizations are prioritizing the diagnosis and management due to which they are highly investing in expansion of healthcare facilities.
• Cardiovascular surgeries are rising due to the high prevalence of stroke and ischemic heart disease due to genetic factors, sedentary lifestyle, smoking, drinking, eating an unhealthy diet, excessive drinking, consuming junk food and staying in high stress.
• These factors lead to rising hospital admissions, thus driving the demand for vascular patches.
• The cardiovascular surgery volume in South Korea, which was estimated at 10,581 in 2014, is expected to steadily rise to 15,501 by 2040, a 46.5% increase. 

High Cost of Advanced Products is Key Challenge for the Market Growth

• The development of high-quality vascular patches requires complex processing and tissue engineering, which makes them more expensive than the traditional synthetic patches.
• The high cost associated with these advanced materials limits their accessibility and makes the entry of small market players difficult.
• The cost of raw materials, such as human and animal tissue, depends upon the supply chain, which can create variations in prices during times of uncertainty due to trade tariffs, limited supply, or geopolitical tension.

Vascular Patches Market Segmentation Analysis

Material Insights

Synthetic patches held the largest market share of 45%, in 2024, This dominance is due to its widespread use, durability, and cost-effectiveness, as they are made of materials such as polyester, polytetrafluorethylene (PTFE), and expanded PTFE. Moreover, they are used in a variety of surgical procedures, such as carotid endarterectomy and coronary artery bypass grafting.

Biological patches will grow at the higher CAGR, of 8.5%, during the forecast period. Biological vascular patches are made from natural tissue, which promotes better healing and integration into the body compared to synthetic options. Additionally, surgeons prefer biological patches as a superior option due to their non-infectious capabilities and less post-operative monitoring requirement.

Based on material type, the market has the following categories:

• Biological (Fastest-Growing Category)
• Synthetic (Largest Category)
• Composite

Application Analysis

Based on application, the CEA category held the largest share, around 40%, in 2024, on account of the rise in the count of such surgeries. A systematic review of randomized clinical trials found that patch angioplasty in traditional CEA could reduce the risk of a recurrent ipsilateral stroke and restenosis, compared to a primary closure. Advanced stent research and development initiatives will also enhance patient outcomes with better endovascular management results.

The prevalence of some CHDs, primarily those of the mild nature, is increasing, while that of others has remained relatively stable. A critical CHD affects about 1 in 4 infants. In their first year of life, infants with such a condition typically require surgery or other interventions.

The vascular bypass surgery category will grow at the higher CAGR of 9%, during the forecast period. With the rise in the incidence of peripheral artery disease (PAD), coronary artery disease, and other vascular conditions, there is a surge in the demand for vascular bypass surgeries. This procedure requires vascular patches to repair and reinforce bypass grafts.

Every year, about 400,000 heart bypass procedures are carried out globally, including 60,000 in India and 20,000 in the U.S. Doctors in India prefer surgery over any other approach because its success rate is 98%, significantly higher than in the U.S.

Additionally, the congenital heart diseases (CHDs) category will show significant growth in the future. ‘CHD’ refers to a variety of structural issues with the heart that exist since birth. Their prevalence is reported to be 8–12 per 1,000 live births. Considering a rate of 9 per 1,000, about 1.35 million babies are born with a CHD each year globally. According to the Centers for Disease Control and Prevention, CHDs are found in nearly 1% or about 40,000 births per year in the U.S.

Based on application, the market has the following categories:

• Carotid Endarterectomy (CEA) (Largest Category)
• Open Abdominal Aortic Aneurysm (AAA) Surgery
• Vascular Bypass Surgery (Fastest-Growing Category)
• Congenital Heart Disease

End User Analysis

Hospitals held the larger market share, of 70%, in 2024. This is because hospitals are the main hubs for high-risk vascular surgeries that require vascular patches. These establishments have dedicated and interdisciplinary departments with trained professionals and advanced equipment for various medical procedures. These places also handle most of the trauma cases resulting from intentional violence and accidents. Since these incidents are characterized by significant blood vessel damage and excessive bleeding, hospitals’ demand for vascular patches continues to burgeon.

Ambulatory surgery centers will grow at the higher CAGR, of 8.8%, during the forecast period. These surgery centers do not require an overnight stay, which make them more cost-effective for patients. Additionally, expansion of the network of ASCs in rural and undeserved areas is enabling access to high-quality minimally invasive vascular treatments to a greater pool of patients.

Based on end user, the market has the following categories:

• Hospitals (Larger Category)
• Ambulatory Surgery Centres (Faster-Growing Category)

Vascular Patches Market Regional Outlook

North America captured the largest revenue share in the market, of around 45%, in 2024. This is attributed to the ongoing development in healthcare technologies, rapidly changing lifestyles, rising prevalence of cardiac diseases and hernia, increasing consumption of alcohol and tobacco, growing obesity levels, and rising substance abuse. Moreover, the surging frequency of product launches and the commercialization of innovative treatments drive the market advance in the region. North America also dominates the market due to the advancements in its healthcare infrastructures and an advantageous insurance reimbursement scenario for vascular treatments.

Moreover, companies in the region are focusing on the development of innovative products. In August 2024, Haemonetics Corporation announced the full market release of its VASCADE MVP XL system for procedures that involve larger sheaths, such as cryoablation and left atrial appendage closure.

Canada is also witnessing a rise in the industry revenue with its advantageous healthcare infrastructure, growing consumer awareness, robust support of the government, and technological advancement in the surgery domain.

Moreover, Europe is the second-largest market due to the presence of prominent research institutions and market players and the favorable regulations of governments that encourage surgeries for the predictive management of diseases.

Furthermore, Germany is showing significant growth in this market. This is owing to the rise in its healthcare budget, adoption of advanced technologies, awareness raising initiatives of the governments, favorable reimbursement policy for vascular procedures, and strong preference for surgeries among healthcare personnel for CHDs.

APAC region will grow at the highest CAGR of 9.2%, during the forecast period. This is due to the rising coronary artery disease, peripheral artery disease and diabetes in the region. Additionally, China is showing significant growth in the vascular patches market of the APAC region. China records a high prevalence of cardiovascular diseases, which are also among the leading causes of death here. This is owing to the consumption of a high-sodium diet and seafood, a sedentary lifestyle, and extensive number of smokers and alcoholics.

Based on geography, the market has the following categories:

• North America (Largest Category)
  • U.S. (Largest and Fastest-Growing Country Market)
  • Canada
• Europe
  • Germany (Largest and Fastest-Growing Country Market)
  • U.K.
  • France
  • Italy
  • Spain
• Asia-Pacific (Fastest-Growing Category)
  • Japan
  • China (Largest-Country Market)
  • India (Fastest-Growing Country Market)
  • South Korea
  • Australia
• Latin America
  • Brazil (Larger-Country Market)
  • Mexico (Faster-Growing Country Market)
• Middle East and Africa
  • Saudi Arabia
  • South Africa (Largest and Fastest-Growing Country Market)
  • U.A.E.

Vascular Patches Market Competitive Landscape

• The vascular patches market is fragmented in nature due to the presence of a large number of players offering a wide range of products, including synthetic, composite, and biological patches.
• Additionally, companies are focusing on technological advancements, such as integrating enhanced materials in vascular patches, for better surgical outcomes.
• Furthermore, large multinational companies, such as Medtronic, W.L. Gore, Bard Peripheral Vascular (BD), CryoLife, and LeMaitre Vascular, are focusing on merger with and the acquisition of smaller regional players.

Vascular Patches Market News

• In January 2025, Stryker Corporation announced the acquisition of Inari Medical for USD 4.9 billion in cash, to enhance Stryker’s portfolio in peripheral vascular disease treatment.
• In June 2024, Haemonetics Corporation launched the new Vascade MVP XL mid-bore venous closure device system with collapsible disc technology and restorable collagen patches.
• In November 2023, Medtronic plc acquired EOFlow Co Ltd., the manufacturer of the EOPatch tubeless with wearable and fully disposable insulin delivery device, for USD 738 million.